Roche (ROG) Given a CHF 290 Price Target at J P Morgan Chase & Co

J P Morgan Chase & Co set a CHF 290 target price on Roche (VTX:ROG) in a research report sent to investors on Thursday. The brokerage currently has a buy rating on the healthcare company’s stock.

Other research analysts also recently issued reports about the company. Credit Suisse Group set a CHF 260 price target on Roche and gave the company a neutral rating in a report on Monday, October 16th. Baader Bank set a CHF 231 price target on Roche and gave the company a neutral rating in a report on Thursday, October 19th. Morgan Stanley set a CHF 260 price target on Roche and gave the company a neutral rating in a report on Friday, December 8th. set a CHF 210 price target on Roche and gave the company a sell rating in a report on Monday, September 18th. Finally, Kepler Capital Markets set a CHF 230 price target on Roche and gave the company a neutral rating in a report on Monday, September 11th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and eight have assigned a buy rating to the company’s stock. The stock presently has an average rating of Hold and a consensus price target of CHF 261.84.

Roche (VTX ROG) traded up CHF 2.40 during trading hours on Thursday, reaching CHF 244.10. The company had a trading volume of 6,110,000 shares, compared to its average volume of 1,710,000. Roche has a 52-week low of CHF 226.10 and a 52-week high of CHF 273.

WARNING: “Roche (ROG) Given a CHF 290 Price Target at J P Morgan Chase & Co” was posted by Week Herald and is the sole property of of Week Herald. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this news story can be viewed at https://weekherald.com/2017/12/15/roche-rog-given-a-chf-290-price-target-at-j-p-morgan-chase-co.html.

Roche Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche (VTX:ROG)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply